Modi Ventures — Pre-Seed & Seed VC Firm

Serif Biomedicines

Pioneering a new category of biotechnology to treat and prevent disease.

Imagenomix

Imagenomix delivers rapid and affordable cancer diagnostic results through advanced AI capabilities so patients receive effective, targeted treatments for their specific cancer type.

Cytospire

Cytospire is developing next generation γδ T cell engagers into impactful cancer therapies.

Breye Therapeutics

Breye Therapeutics provides treatment solutions for patients at risk of vision loss and blindness by developing orally administered therapies for patients with deteriorating vision from retinal vascular diseases within ophthalmology.

Exciva

Exciva is developing a groundbreaking therapy that effectively and safely addresses neuropsychiatric symptoms of dementia including agitation/aggression in Alzheimer’s disease dementia.

Proxima

Proxima is pioneering the next generation of AI-driven drug discovery for proximity-based therapeutics.

Eridu

Eridu is the pioneer advancing the frontier in AI networking with a solution built from the ground up to deliver the bandwidth, performance and reliability at scale needed by AI data centers.

Early

Early brings early disease detection to the comfort of our homes with devices that are accurate, easy to use and beautiful.

ProFound Therapeutics

We have discovered a vast, expanded universe of novel proteins encoded by the human genome. In analyzing these proteins, we elucidate their respective biological functions, refining our understanding of the molecular underpinnings of human biology and disease.

Kamau Therapeutics

Kamau Therapeutics is a clinical-stage, next-generation gene correction company harnessing high efficiency targeted gene integration to develop a new class of therapies with the aim to cure a wide range of serious and life-threatening diseases.